MEDICAL DEVICE DISINFECTANT SYSTEM FOR HEALTHCARE FACILITIES

CHALLENGE: Address the growing infection control challenges of healthcare facilities with a fast point-of-care disinfectant system

SERVICES: Insights, Industrial Design, Engineering, Prototyping, Sourcing, Manufacturing

AWARDS / PRESS: Medical Device + Diagnostic Industry; Daily Record News; Industry Week; GeekWire

SUCCESS: The first sterilization system to clean complex medical devices & electronics; EPA hospital-grade disinfectant 

Sterifre-Aura-heroAbove: AURA is an elegant technology that manifests itself in a relatively simple design.

Hospital acquired infections (HAI) are the #1 quality and safety issue for healthcare facilities, affecting nearly 5% of all patients and causing 100,000 deaths annually. This is greater than the number of deaths from diabetes and prostate cancer combined.These cases burden the U.S. healthcare industry with over $35B a year in unreimburseable costs, fueling sales of $1.5B worth of infection prevention products. This legacy market has existing solutions, ranging from low cost disinfectant wipes and sprays to expensive capital equipment. However, none of these current technologies completely addresses the growing needs of this market and, in particular, the demand for fast and flexible point of care infection control.

Sterifre Medical Inc. (Sterifre) is commercializing a flexible disinfection process that is poised to address the growing infection control challenges of healthcare facilities. The company’s patented AURA System is comprised of microspray hydrogen and cold plasma ozone in unique combinations, operating at room temperature and atmospheric pressure. These conditions enable fast point of care disinfection of a broad range of devices and sensitive materials commonly used in healthcare facilities, including plastics, metals, glass and electronics. This contrasts with existing technologies, which employ harsh chemicals, heat, and/or operate under vacuum, ultimately limiting material and device compatibility. Additionally, the system is designed to reduce ongoing capital and operating expenses for the customer.

The company is working to obtain an expedited registration with the Environmental Protection Agency, which regulates microbicides used for hospital disinfection. Sterifre is concurrently seeking EPA approval under the Emerging Viral Pathogens Program for inactivating SARS-CoV-2, the coronavirus that causes COVID-19.

Sterifre-Aura-Open

A DEVICE TO STOP THE SPREAD OF COVID-19

Sterifre Medical Seeks Expedited Approval To Help Fight COVID-19

The AURA system uses a patented application of hydrogen peroxide to inactivate microorganisms; it can help address critical shortages and speed delivery of care.

The Aura competitive advantage

AURA is an elegant technology that manifests itself in a relatively simple design. The system was designed with low cost of goods and “plug and play” features that require little personnel training. AURA can be configured to process items at point-of-care, including both countertop & wall-mounted units and large volume industrial units. This enables Sterifre to develop products specific to application, market segment, and environment of use. Such scalability is derived from the initial product designs, which were microwave oven-sized, weighing 23 lbs.

The design requires no special electrical, plumbing, or ventilation connections, a feature carried forward in the company’s first product. This design enables point of care applications, outside of central sterile processing, where existing infection control products (wipes, sprays, hand sanitizers) do not fully address healthcare facility compliance and material compatibility needs. 

Ultimately, AURA will enable hospitals to:

  • ensure compliance with infection prevention protocols

  • automate existing manual processes to allow more hands-on patient care

  • reduce the environmental impact of discarding chemically treated wipes

  • reduce the incidence of equipment damage from harsh chemicals during disinfection with wipes

  • protect staff from health risks associated with occupational exposure to disinfectants

Sterifre Aura Disinfectant Medical Device Innovation

 

bottom banner

MORE CASE STUDIES

cardinal-health-inpower-featured-image

CARDINAL HEALTH INPOWER

A CONNECTED CONSUMER MEDICAL DEVICE TO IMPROVE MEDICATION ADHERENCE RATES

tactile-medical-flexitouch-plus-innovaton

TACTILE MEDICAL

MEDICAL DEVICE INNOVATION FOR AT-HOME LYMPHATIC DRAINAGE

Navage Home Healthcare Consumer Product Development

Naväge

DISRUPTIVE NASAL IRRIGATION PRODUCTS

CONTACT US

Learn how Nottingham Spirk can help you design and commercialize your next product innovation.